NTRBW logo

Nutriband Inc. Warrant


NTRBW: Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.


Show NTRBW Financials

Consumer Interest
SEC Filings

Recent trades of NTRBW by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by NTRBW's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of NTRBW in WallStreetBets Daily Discussion


Recent insights relating to NTRBW

CNBC Recommendations

Recent picks made for NTRBW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NTRBW

Corporate Flights

Flights by private jets registered to NTRBW